---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "H+pCS3qb5FpNZoBIac5TPyvzI7HBw4vxh9MEhhO9wkRi2uCdAdzfOEwVo0AzjXXobzsJeGK2wgVyCVnKz1nQPlF6XIzA79mG79vESGEiuijF8haCVZS6TgDVVLTU5OXRGkAuBEfD3YPodKUmnh8Rk6VFsTjtgrm89DCNInf0SuxGeBk6dogmVlxvTo5MOjSsp24HtBuw1XsfkMSkLEr34tXH4rajwFXUHO7jGCMfDuAyy+28o4d6ncMkUx+Db4Bn8BRIEXqMl6c1PNrK99SJ0g6SUvjj5ol6eQqs0VY7y/Cj82JXsacB5fdQTGMmf5Na6c681cXo4TgVmZQCchFQuFBqlfv4E41PvzmNX/raDNM=;pQjdB/GiZLOMmI7mEn3b0w=="
---

